| Profitability | 23/100 |
| Growth | 46/100 |
| Momentum | 78/100 |
| Quality | 71/100 |
| Earnings Quality | 75/100 |
| Balance Sheet | 50/100 |
| Value | 57/100 |
| Risk (safety) | 30/100 |
| Overall | 39.5/100 |
| Symbol | IS Score |
|---|---|
| PPG | 69 |
| LYB | 32 |
| SQM | 81 |
| RPM | 62 |
| ALB | 72 |
| SOLS | 45 |
| IFF | 39 |
These two disagree — business quality 39, price structure 92 out of 100, so the price reads better than the business does. We publish the disagreement rather than resolving it: they answer different questions, and the gap between them is information, not an error.
| Trigger | Where it stands now | What it would mean |
|---|---|---|
| IS Score reaches 55 and holds two consecutive quarters | now 39.5 | would move us up one band |
| IS Score stops falling - one quarter higher than the prior | last four: 30 → 16 → 38 → 39 | the direction matters more than the level |
| Technical vote share back above 50% | now 100% | price structure no longer broken |
| Institutional holder count rises two quarters running | peak 788 → now 756 | fewer institutions willing to hold is our clearest warning |
This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.
| Quarter | Holders | 13F shares | Value | Reported own% | Guard |
|---|---|---|---|---|---|
| 2026 Q2 | 756 | 273.6M | $21.6B | 106.9% | ex-outlier 92.4% |
| 2026 Q1 | 706 | 257.2M | $18.5B | 100.5% | ex-outlier 86.2% |
| 2025 Q4 | 711 | 255.9M | $17.1B | 99.9% | |
| 2025 Q3 | 706 | 242.6M | $14.7B | 94.8% | |
| 2025 Q2 | 691 | 241.3M | $17.3B | 94.3% | |
| 2025 Q1 | 722 | 239.1M | $18.0B | 93.4% | |
| 2024 Q4 | 763 | 238.2M | $19.7B | 93.0% | |
| 2024 Q3 | 788 | 231.0M | $23.6B | 90.2% | |
| 2024 Q2 | 772 | 234.7M | $21.8B | 91.7% | |
| 2024 Q1 | 748 | 236.3M | $19.3B | 92.3% | |
| 2023 Q4 | 766 | 234.0M | $18.4B | 91.4% | |
| 2023 Q3 | 739 | 235.6M | $16.0B | 92.0% |
Why 2026-06 reads 106.89%. Institutions cannot hold more of a company than exists. The reported 273.6M shares exceed the 256.0M outstanding, and a single filer accounts for the excess: Dodge & Cox reports 37,007,037 shares against 36,472,942 the prior quarter, a 1x jump, which alone would be 14.5% of the company. Excluding that filing, ownership is 92.4%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.
Why 2026-03 reads 100.47%. Institutions cannot hold more of a company than exists. The reported 257.2M shares exceed the 256.0M outstanding, and a single filer accounts for the excess: Dodge & Cox reports 36,472,942 shares against 36,401,042 the prior quarter, a 1x jump, which alone would be 14.2% of the company. Excluding that filing, ownership is 86.2%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.
| Insider | Role | Date | Type | Shares | Value | Post-Txn Owned |
|---|---|---|---|---|---|---|
| Teles De Mendonca Ana Paula | President, Scent | 2026-08-17 | SELL | 5,718 | $0.48M | 0 |
| Birenkrant Marc | Controller & CAO | 2026-08-07 | SELL | 1,000 | $0.09M | 3,446 |
| Deveau Michael | EVP, CFO | 2026-08-06 | SELL | 8,825 | $0.75M | 5,199 |
| Fribourg Paul J | director | 2026-06-01 | BUY | 13,500 | $1.01M | 43,150 |
| Fribourg Paul J | director | 2026-06-01 | BUY | 260,000 | $19.31M | 2,682,730 |
| Teles De Mendonca Ana Paula | President, Scent | 2026-05-04 | EXERCISE | 708 | — | 19,156 |
| Teles De Mendonca Ana Paula | President, Scent | 2026-05-04 | EXERCISE | 708 | — | 6,080 |
| Teles De Mendonca Ana Paula | President, Scent | 2026-05-04 | TAX W/H | 362 | $0.03M | 5,718 |
| 6-mo decomposition (Form 4) | Txns | Shares | Value | Signal weight |
|---|---|---|---|---|
| S — Open-market sales | 3 | 15,543 | $1.3M | Counted |
| P — Open-market purchases | 7 | 443,963 | $32.3M | Counted |
| M — Exercises (paired A/D) | 28 | 93,046 | — | None — mechanics |
| F — Tax withholding | 24 | 38,099 | $2.7M | None — compensation |
| Filed | Filer | Shares registered | Est. proceeds |
|---|---|---|---|
| 2026-08-17 | Teles De Mendonca Ana Paula | 5,718 | $0.5M |
| 2026-08-07 | Birenkrant Marc | 1,000 | $0.1M |
| 2026-08-06 | Deveau Michael | 8,825 | $0.8M |
| 2025-11-07 | Yildiz Beril | 4,060 | $0.3M |
| Trailing 12 mo | 4 filings | 19,603 | $2M |
| Filed | Form | Reporting person | % of class | Shares |
|---|---|---|---|---|
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.37% | 18.8M sh |
| 2026-03-27 | SCHEDULE 13G/A | The Vanguard Group | — | exit/reporting change |
| 2025-08-13 | SCHEDULE 13G/A | Dodge & Cox | 13.70% | 35.0M sh |
| 2025-04-24 | SCHEDULE 13G/A | BlackRock, Inc. | 7.00% | 18.0M sh |
| Member | Chamber | Trade | Size band | Traded | Disclosed |
|---|---|---|---|---|---|
| Michael McCaul | House | BUY | $50,001 - $100,000 | 2026-01-15 | 2026-02-12 |
| Michael T. McCaul | House | BUY | $50,001 - $100,000 | 2026-01-15 | 2026-02-12 |
| Michael McCaul | House | BUY | $100,001 - $250,000 | 2026-01-13 | 2026-02-12 |
| Gary Peters | Senate | SELL | $15,001 - $50,000 | 2024-05-14 | 2024-05-23 |
| Gary Peters | Senate | SELL | $15,001 - $50,000 | 2024-05-14 | 2024-05-22 |
| Gary C. Peters | Senate | SELL | $15,001 - $50,000 | 2024-05-14 | 2024-05-22 |
| Manager | Shares | Value |
|---|---|---|
| Fort Washington Investment Advisor | 1.4M | $121M |
| Davenport & Co Llc | 873,807 | $73M |
| Deprince Race & Zollo Inc | 437,557 | $37M |
| Douglas Lane & Associates, Llc | 367,492 | $31M |
| Zwj Investment Counsel Inc | 341,237 | $28M |
| Cantor Fitzgerald Investment Advis | 208,502 | $17M |
| Fund | Weight | Position |
|---|---|---|
| VITSX | 0.0% | $640M |
| VSMPX | 0.0% | $640M |
| VTI | 0.0% | $640M |
| VTSAX | 0.0% | $640M |
| VOO | 0.0% | $559M |
| VFINX | 0.0% | $559M |
| ATS Venue (4-wk) | Shares | Avg trade |
|---|---|---|
| Incr Intelligent Cross Llc | 2.1M | 51 sh |
| Ubsa Ubs Ats | 1.7M | 62 sh |
| Mstx Ms Trajectory Cross (Ats-1) | 1.0M | 40 sh |
| Ebxl Level Ats | 1.0M | 24 sh |
| Sgmt Sigma X2 | 0.9M | 39 sh |
| Mlix Instinct X | 0.8M | 59 sh |
| Region | Revenue | Share |
|---|---|---|
| EMEA | $3.7B | 27% |
| North America | $3.2B | 23% |
| UNITED STATES | $3.1B | 22% |
| Asia | $2.5B | 18% |
| Latin America | $1.4B | 10% |
Moat score 47/100 — Weak; primary source Intangible Assets.
| Officer | Title |
|---|---|
| J. Erik Fyrwald | Chief Executive Officer & Director |
| Leticia Goncalves Lourenco | President of Health & Biosciences |
| Yuvraj Arora | President of Taste Division & Chief Commercial Officer |
| Andres Muller | President of Food Ingredients |
| Period | EPS est. | EPS actual | EPS surprise | Rev est. ($M) | Rev actual ($M) | Rev surprise |
|---|
| YoY growth | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | +129.3% | +6.7% | -7.7% | +0.0% | -5.2% |
| Gross profit | +79.1% | +11.1% | -11.3% | +12.0% | -18.3% |
| Operating income | +3.4% | -326.7% | +59.1% | -136.3% | +30.5% |
| Net income | -26.6% | -797.0% | +37.3% | -109.5% | -253.9% |
| $B · FY ends | FY21 | FY22 | FY23 | FY24 | FY25 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 11.7 | 12.4 | 11.5 | 11.5 | 10.9 | |
| Cost of revenue | 7.9 | 8.3 | 7.8 | 7.4 | 7.5 | |
| Gross profit | 3.7 | 4.2 | 3.7 | 4.1 | 3.4 | |
| R&D expense | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| SG&A expense | 1.7 | 1.8 | 1.8 | 2.0 | 1.7 | |
| Operating income | 0.6 | -1.3 | -2.1 | 0.8 | 1.0 | |
| EBITDA | 1.8 | -0.1 | -1.0 | 1.6 | 0.8 | |
| D&A | 1.2 | 1.2 | 1.1 | 1.0 | 1.0 | |
| Pretax income | 0.4 | -1.6 | -2.5 | 0.3 | -0.4 | |
| Income tax | 0.1 | 0.2 | 0.0 | 0.0 | -0.0 | |
| Net income | 0.3 | -1.9 | -2.6 | 0.2 | -0.4 | |
| Diluted EPS ($) | 1.10 | -7.20 | -10.06 | 0.95 | -1.46 | |
| Diluted shares (M) | 243 | 255 | 255 | 256 | 256 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Cash & equivalents | 0.5 | 0.7 | 0.5 | 0.6 | |
| ST investments | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables (net) | 2.2 | 2.1 | 2.0 | 2.0 | |
| Total current assets | 7.4 | 6.3 | 8.0 | 5.6 | |
| PP&E (net) | 5.0 | 5.0 | 4.3 | 4.6 | |
| Goodwill + intangibles | 22.5 | 19.0 | 15.5 | 14.3 | |
| Total assets | 35.5 | 31.0 | 28.7 | 25.5 | |
| Accounts payable | 1.4 | 1.4 | 1.3 | 1.3 | |
| Short-term debt | 0.6 | 0.9 | 1.4 | 1.4 | |
| Deferred revenue | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total current liabilities | 3.7 | 3.8 | 4.3 | 3.9 | |
| Long-term debt | 10.4 | 9.2 | 7.6 | 4.7 | |
| Total liabilities | 17.8 | 16.3 | 14.8 | 11.4 | |
| Shareholders' equity | 17.7 | 14.6 | 13.9 | 14.2 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Net income | (1.8) | (2.6) | 0.2 | (0.4) | |
| D&A | 1.2 | 1.1 | 1.0 | 1.0 | |
| Stock-based compensation | 0.0 | 0.1 | 0.1 | 0.0 | |
| Working capital change | (1.1) | 0.5 | (0.1) | (0.4) | |
| Operating cash flow | 0.4 | 1.4 | 1.1 | 0.9 | |
| Capital expenditures | (0.5) | (0.5) | (0.5) | (0.6) | |
| Investing cash flow | 0.7 | 0.6 | 0.3 | 2.3 | |
| Buybacks | 0.0 | 0.0 | (0.0) | (0.0) | |
| Dividends paid | (0.8) | (0.8) | (0.5) | (0.4) | |
| Debt issuance / (repay) | (0.3) | (0.9) | (1.0) | (2.6) | |
| Financing cash flow | (1.2) | (1.9) | (1.6) | (3.1) | |
| Free cash flow | (0.1) | 0.9 | 0.6 | 0.3 |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| PROFITABILITY | |||||||
| ROE | 1.9% | -9.7% | -15.9% | 1.7% | -2.4% | 2% | |
| ROA | 1.0% | -5.0% | -7.7% | 0.8% | -1.2% | 1.2% | |
| ROIC | 1.4% | -3.6% | -6.7% | 3.0% | -1.4% | 2.8% | |
| Gross margin | 32.0% | 33.4% | 32.1% | 35.9% | 30.9% | 37.5% | |
| Operating margin | 5.0% | -10.7% | -18.4% | 6.7% | 9.2% | 7.8% | |
| Net margin | 2.3% | -15.0% | -22.3% | 2.1% | -3.4% | 2.9% | |
| EBITDA margin | 15.4% | -0.9% | -8.7% | 13.9% | 7.2% | 14.9% | |
| FCF margin | 8.9% | -0.9% | 8.2% | 5.2% | 2.3% | — | |
| VALUATION | |||||||
| P/E | 129.18 | -13.17 | -7.73 | 87.04 | -51.70 | 83.2 | |
| P/B | 1.63 | 1.39 | 1.36 | 1.52 | 1.22 | 1.7 | |
| P/S | 2.95 | 1.98 | 1.73 | 1.84 | 1.59 | 2.32 | |
| P/FCF | 33.04 | -225.90 | 21.18 | 35.13 | 68.19 | 43.2 | |
| EV/EBITDA | 25.49 | -326.23 | -28.74 | 18.96 | 28.90 | 19.4 | |
| EV/Revenue | 3.93 | 2.88 | 2.61 | 2.64 | 2.15 | 2.9 | |
| Earnings yield | 0.8% | -7.6% | -12.9% | 1.1% | -1.9% | 1.25% | |
| FCF yield | 3.0% | -0.4% | 4.7% | 2.8% | 1.5% | 2.32% | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| LEVERAGE & SOLVENCY | |||||||
| Current ratio | 1.92 | 1.99 | 1.67 | 1.84 | 1.42 | 2.06 | |
| Quick ratio | 1.23 | 1.11 | 0.97 | 1.32 | 0.82 | 1.72 | |
| Debt / equity | 0.58 | 0.67 | 0.74 | 0.69 | 0.47 | 0.45 | |
| Debt / assets | 30.8% | 33.1% | 34.9% | 33.6% | 26.0% | 24.8% | |
| Net debt / EBITDA | 6.39 | -102.38 | -9.71 | 5.73 | 7.49 | 3.82 | |
| Interest coverage | 2.22 | -3.84 | -6.54 | 1.91 | -0.67 | — | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| EFFICIENCY | |||||||
| Asset turnover | 0.44 | 0.33 | 0.35 | 0.39 | 0.40 | 0.40 | |
| Receivables turnover | 8.22 | 6.68 | 6.48 | 6.86 | 6.49 | 5.5 | |
| DSO (days) | 44 | 55 | 56 | 53 | 56 | 67 | |
| DPO (days) | 48 | 65 | 65 | 66 | 67 | 62 | |
| Cash conversion cycle | 80 | 118 | 130 | 109 | 110 | 93 | |
| GROWTH (YoY) | |||||||
| Revenue growth | 129.3% | 6.7% | -7.7% | 0.0% | -5.2% | — | |
| Net income growth | -26.2% | -803.0% | -37.1% | 109.5% | -237.9% | — | |
| EPS growth | -67.1% | -803.0% | -37.1% | 109.4% | -237.3% | — | |
| FCF growth | 99.1% | -110.5% | 958.7% | -35.7% | -57.8% | — | |
| PER SHARE ($) | |||||||
| EPS (diluted, TTM) | 1.04 | -7.33 | -10.05 | 0.95 | -1.30 | 1.13 | |
| Book value / share | 82.67 | 69.24 | 57.30 | 54.20 | 55.07 | 54.72 | |
| Revenue / share | 45.71 | 48.78 | 45.02 | 44.86 | 42.37 | 38.98 | |
| FCF / share | 4.08 | -0.43 | 3.67 | 2.35 | 0.99 | 2.09 | |
| Cash / share | 2.79 | 1.89 | 2.76 | 1.83 | 2.30 | 2.22 | |
| SHAREHOLDER RETURN & SCORES | |||||||
| Buyback yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.54% | |
| Altman Z-Score | 1.70 | 1.22 | 0.85 | 1.35 | 1.21 | 1.7 | |
| Piotroski F-Score | 6 | 5 | 4 | 8 | 4 | 7/9 | |
| Beneish M-Score | -1.12 | -2.84 | -3.20 | -2.81 | -2.67 | -2.86 | |
| Model | Score | Zone | Note |
|---|---|---|---|
| Piotroski F-Score | 7 / 9 | Strong | |
| Altman Z-Score | 1.7 | Distress (<1.81) | Distress |
| Income quality | N/M | Loss-making | OCF ÷ net income not meaningful with negative earnings; OCF itself is the signal |
| Beneish M-Score | -2.86 | Non-manipulator | vs −2.22 threshold |
| DuPont Decomposition (TTM) | Value |
|---|---|
| Tax burden | 0.83 |
| Interest burden | 0.65 |
| Operating margin | 5.4% |
| Asset turnover | 0.39× |
| Financial leverage | 1.81× |
| = ROE | 2% |
| Growth Quality (live) | Value |
|---|---|
| Revenue stability | 0.23 |
| Earnings stability | 0.01 |
| Earnings persistence | 0.20 |
| Revenue CAGR 3y | -5.6% |
| EPS CAGR 3y | — |
| FCF CAGR 3y | 26.5% |
| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | Piotroski | 1-yr ret |
|---|---|---|---|---|---|---|---|
| PPG | $23.9B | 15.3 | 20% | 9.7% | +12.3% | 8/9 | +7.1% |
| LYB | $20.7B | -57.2 | -3% | 6.1% | -11.3% | 3/9 | +43.6% |
| SQM | $17.2B | 12.5 | 24% | 26.7% | +59.3% | 7/9 | +35.6% |
| RPM | $12.7B | 18.4 | 21% | 11.6% | +6.0% | 6/9 | -11.1% |
| ALB | $11.3B | 198.9 | 2% | 27.5% | +18.3% | 7/9 | — |
| SOLS | $9.4B | 44.5 | 15% | 10.4% | — | 4/9 | — |
| ESI | $8.5B | 47.7 | 7% | 7.9% | +26.6% | 4/9 | — |
| WLK | $8.1B | -6.6 | -13% | 7.9% | -4.0% | 3/9 | — |
| Consensus estimates | Revenue mean | High / Low | EPS mean | High / Low | # EPS est. |
|---|---|---|---|---|---|
| FY2026 | $7.75B | $7.79B / $7.71B | $3.32 | $4.48 / $2.46 | 8 |
| FY2027 | $7.83B | $7.96B / $7.68B | $3.89 | $5.04 / $2.79 | 10 |
| FY2028 | $8.18B | $8.40B / $7.94B | $4.48 | $5.34 / $3.17 | 4 |
| Window | Avg Target | vs. Price | # Targets |
|---|---|---|---|
| Last Month | $100.00 | +10.3% | 2 |
| Last Quarter | $96.43 | +6.3% | 7 |
| Last Year | $89.65 | -1.1% | 23 |
| All Time | $99.94 | +10.2% | 53 |
| Moving Average | Value | Distance | % Distance | Signal |
|---|---|---|---|---|
| SMA 20 | $85.54 | +5.14 | +6.01% | Above |
| SMA 50 | $85.08 | +5.60 | +6.58% | Above |
| SMA 200 | $77.30 | +13.38 | +17.31% | Above |
| EMA 9 | $87.62 | +3.06 | +3.49% | Above |
| EMA 21 | $86.07 | +4.61 | +5.36% | Above |
| EMA 50 | $84.41 | +6.27 | +7.43% | Above |
| EMA 200 | $78.55 | +12.13 | +15.44% | Above |
| Level | Value | Level | Value |
|---|---|---|---|
| Pivot / R1 / R2 | $90.48 / $91.50 / $92.70 | S1 / S2 | $89.28 / $88.26 |
| Bollinger (20,2) | $80.89 – $90.19 | Squeeze | Off |
| 52-wk range | $60.92 – $91.79 | Off 52-wk high | -1.2% |
| ATR (14) | $1.85 (2.0%) | Historical vol | 19.7% |
| Computed from live weekly prices | IFF | S&P 500 |
|---|---|---|
| Weekly volatility (σ, 1y) | 4.88% | 1.83% |
| Best / worst week (1y) | +14.5% / -9.8% | — |
| Max drawdown (5y, monthly) | -56.2% | — |
| 1-week VaR (95%) | -7.2% | — |
| Beta (5y) | 0.95 | 1.00 |
| Reading | IFF | Chemicals - Specialty n=1,191 | Basic Materials n=7,383 | All US symbols n=70,435 |
|---|---|---|---|---|
| Overall | +27.6 | -21.1 | -30.9 | -20.5 |
| Trend | +46.3 | -21.0 | -33.0 | -21.3 |
| Momentum | +73.4 | -20.1 | -31.5 | -15.8 |
| Volume | +40.9 | +1.5 | -34.6 | -3.8 |
| Executive | Total comp | Structure |
|---|---|---|
| J. Erik Fyrwald CEO | $15.0M | 91% equity+incentive |
| Leticia Gonçalves Lourenço President, Health | $5.8M | 72% equity+incentive |
| Yuvraj Arora President, Taste | $4.7M | 82% equity+incentive |
| Jennifer Johnson Former EVP, General Counsel | $4.0M | 44% equity+incentive |
| Michael DeVeau Chief Financial Officer | $3.7M | 80% equity+incentive |
| Pillar (live disclosure scores) | Score |
|---|---|
| Environmental | 69 |
| Social | 68 |
| Governance | 67 |
| Composite ESG | 68 |
| Filed | 8-K contents | Items |
|---|---|---|
| 2026-08-04 | Earnings Release; Other Events; Exhibits | 2.02,8.01,9.01 |
| 2026-08-04 | Regulation FD; Exhibits | 7.01,9.01 |
| 2026-06-23 | Material Agreement; Financial Obligation; Exhibits | 1.01,2.03,9.01 |
| 2026-06-01 | Material Agreement; Other Events; Exhibits | 1.01,8.01,9.01 |
| 2026-05-05 | Earnings Release; Exhibits | 2.02,9.01 |
| 2026-05-04 | Shareholder Vote | 5.07 |
| 2026-02-11 | Results of Operations and Financial Condition; Financial Statements an | 2.02,9.01 |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements an | 2.02,9.01 |
Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.
| Data domain | Source | Coverage for this report |
|---|---|---|
| Price & volume | market_db.historical_prices | 52 rows |
| Fundamentals | income_statements_annual | 6 rows · 2020 to 2025 |
| Reported vs consensus | fact/earnings_calendar | 24 rows · 2020-11-09 to 2026-08-04 |
| Analyst estimates | dim/forward_estimates | 3 rows · 2026-12-31 to 2028-12-31 |
| Institutional ownership (13F) | holdings_db.institutional_ownership_summary | 119 rows · 1996 to 2026 |
| Insider transactions (Form 4) | edgar/form4 | 12 rows · 2026-05-04 to 2026-08-17 |
| Proposed sales (Form 144) | edgar/form144 | 1 record |
| Beneficial ownership (13D/G) | edgar/13dg | 4 rows · 2025-04-24 to 2026-04-30 |
| Short-sale volume (FINRA) | edgar/short_volume_daily | 60 rows · 2026-07-23 to 2026-10-15 |
| Dark pool (ATS, tier 1) | edgar/darkpool_weekly | 12 rows · 2026-06-15 to 2026-08-31 |
| ETF & fund holding | etf_holdings_changelog (30d) | 1 record |
| Peer set | stock_peers_dynamic | 8 rows |
| Industry medians | industry_medians | 1 record |
| Congressional trades | congress_db (House + Senate) | 1 record |
| ESG | fact/esg_disclosures | 1 record |
Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.
Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.